ReviewClinical medicine (London, England)2019
Acute pulmonary embolism.
Review in Clinical medicine (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05469724 (Clinical Characteristics and Outcome Registry in Patients Admitted With Acute Pulmonary Embolism), which is not on this map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical Characteristics and Outcome Registry in Patients Admitted With Acute Pulmonary Embolism
Who cites it
33 citing papers in PubMed.
- Predictive value of a combined clinical, serum biomarker, and radiomic model for poor short-term prognosis in acute pulmonary embolism.The international journal of cardiovascular imaging · 2026Review
- A preliminary study on predicting the stability of external Iliac vein thrombosis using CT texture analysis.BMC medical imaging · 2025Article
- Use of the PaOJournal of thoracic disease · 2025Article
- Electron density derived from dual-energy CT for predicting thrombolytic therapeutic efficacy in patients with pulmonary embolism.Japanese journal of radiology · 2025Article
- Article
- Evaluation of NAPLES Prognostic Score to Predict Long-Term Mortality in Patients with Pulmonary Embolism.Diagnostics (Basel, Switzerland) · 2025Article
- The value of thrombus markers applied in patients with respiratory failure.Journal of medical biochemistry · 2025Article
- Dynamic EIT technology for real-time non-invasive monitoring of acute pulmonary embolism: a porcine model experiment.Respiratory research · 2025Article
- Influence of an Alternative Diagnosis on the Diagnosis of Pulmonary Thromboembolism.Healthcare (Basel, Switzerland) · 2024Article
- Article
- Clinical Symptoms and Echocardiographic Markers Regarding the Severity of Embolism in Patients with Acute Pulmonary Embolism.Tanaffos · 2024Article
- Lipid-to-neutrophil ratios in predicting in-hospital outcomes in pulmonary thromboembolism.Journal of cardiovascular and thoracic research · 2024Article
- Overcoming challenges in the treatment of massive pulmonary embolism in the elderly: Role of extracorporeal membrane oxygenation.Respiratory medicine case reports · 2024Article
- Development and validation of a novel model to predict pulmonary embolism in cardiology suspected patients: A 10-year retrospective analysis.Open medicine (Warsaw, Poland) · 2024Article
- Association between statin use and acute pulmonary embolism in intensive care unit patients with sepsis: a retrospective cohort study.Frontiers in medicine · 2024Article
- Article
- Does Adding the Pulmonary Infarction and Right Ventricle to Left Ventricle Diameter Ratio to the Qanadli Index (A Combined Qanadli Index) More Accurately, Predict Short-Term Mortality in Patients with Pulmonary Embolism?The Indian journal of radiology & imaging · 2023Article
- [Analysis of the Incidence of Lower Limb Deep Venous Thrombosis and Its Related Risk Factors in the Postoperative Patients with Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2023Article
- An efficient machine learning framework to identify important clinical features associated with pulmonary embolism.PloS one · 2023Article
- Oxygenation index and NT-proBNP as predictors of pulmonary hypertension and ventilation/perfusion mismatch in acute pulmonary embolism.Frontiers in cardiovascular medicine · 2023Article
Corrections and comments
- Commented on by
- Erratum issued
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary embolism, despite being common, often remains elusive as a diagnosis, and clinical suspicion needs to remain high when seeing a patient with cardiopulmonary symptoms. Once suspected, diagnosis is usually straightforward; however, optimal treatment can be difficult. Risk stratification with clinical scores, biomarkers and imaging helps to refine the best treatment strategy, but the position of thrombolysis in intermediate risk (submassive) pulmonary embolism remains a grey area. Pulmonary embolism response teams are on the increase to provide advice in such cases. Direct oral anticoagulants have been a major advance in treatment this decade, but are not appropriate for all patients. Follow-up of patients with pulmonary embolism should be mandatory to determine duration of anticoagulation and to assess for serious long-term complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.